TENET HEALTHCARE CORP
For the period ended Mar 31, 2025. Filed Apr 29, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 29, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(c) Trading Plans
During the three months ended March 31, 2025, one of our directors adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K); the terms of this arrangement, which is intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c) under the Exchange Act, are as follows:
| Name | Title | Adoption Date | Expiration Date | Aggregate Number of Shares of Common Stock To Be Sold |
|---|---|---|---|---|
| James L. Bierman | Director | February 20, 2025 | February 20, 2026 | 20,000 |
Other than as disclosed above, none of our directors or Section 16 officers adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, during the three months ended March 31, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.